Wada et al., 1996 - Google Patents
Effects of Perfluorochemical‐Based Artificial Blood Compounds in Discordant XenotransplantationWada et al., 1996
- Document ID
- 12215728397174771268
- Author
- Wada S
- Kajihara H
- Murakami H
- Sueda T
- Matsuura Y
- Publication year
- Publication venue
- Artificial organs
External Links
Snippet
Fluosol‐DA and FC43 emulsion were developed as red blood cell substitutes. However, these perfluorochemical (PFC)‐based compounds are not very promising because of their immunosuppressive effects. Therefore we used these compounds as immunosuppressive …
- 150000001875 compounds 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100502650C (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
| AU2002318377A1 (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
| JP2012523432A (en) | Methods for treating edema associated with ischemia-reperfusion | |
| US6321909B1 (en) | System for storing polyethylene glycol solutions | |
| RU2014837C1 (en) | Drug for treatment of pancreatitis and prevention of pancreas transplant detachment, and a method of prevention of pancreas transplant detachment | |
| CN109511650B (en) | Normal-temperature mechanical perfusate capable of enlarging liver supply source | |
| Bullough et al. | The lymphocytic chalone and its antimitotic action on a mouse lymphoma in vitro | |
| BROWN et al. | Pancreas transplantation for diabetes mellitus | |
| JP5562939B2 (en) | Actin cytoskeletal rearrangement and method of regulation of intercellular gap formation | |
| Wada et al. | Effects of Perfluorochemical‐Based Artificial Blood Compounds in Discordant Xenotransplantation | |
| Martin et al. | Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia | |
| Reilmann et al. | Regeneration and function of autologous splenic grafts in pigs | |
| Ibla et al. | Lung growth after reduced size transplantation in a sheep model1 | |
| Ramos et al. | The presence of humoral factors in homograft rejection of the transplanted heart | |
| JPH11228442A (en) | Use of fructose diphosphate for reducing cyclosporin dose after organ transplantation | |
| Glaumann | Effect of mannitol, dextran (Macrodex®), allopurinol, and methylprednisolone on the morphology of the proximal tubule of the rat kidney made ischemic in vivo | |
| Suzuki et al. | Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat1 | |
| XENOCOSTAS et al. | THE EFFECT OF THE GRAFT-VERSUS-HOST REACTION ON B LYMPHOCYTE PRODUCTION IN BONE MARROW OF MICE: DEPRESSED GENESIS OF EARLY PROGENITORS PRIOR TO μ HEAVY CHAIN EXPRESSION | |
| Bolys et al. | Vascular function in the cadaver up to six hours after cardiac arrest | |
| JP2000512625A (en) | Compositions and methods for preserving living tissue | |
| JP2956998B2 (en) | Preservative solution for transplant organ perfusion and preservation method for transplant organ perfusion | |
| KANEKO et al. | A simple, working heart and lung transplant model for assessing preservation methods in the rabbit | |
| Rao et al. | Effects of metabolic stimulation on cardiac allograft recovery | |
| EP0219716A2 (en) | Immunosuppressive agent | |
| CN117323444A (en) | Intelligent drug delivery system and preparation method and application thereof |